Kazia Therapeutics (KZIA) Equity Ratio (2017 - 2025)

Kazia Therapeutics' Equity Ratio history spans 6 years, with the latest figure at 1.37 for Q2 2025.

  • For Q2 2025, Equity Ratio fell 195.12% year-over-year to 1.37; the TTM value through Jun 2025 reached 0.08, changed N/A, while the annual FY2025 figure was 1.37, 195.12% down from the prior year.
  • Equity Ratio reached 1.37 in Q2 2025 per KZIA's latest filing, down from 0.46 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.51 in Q2 2022 to a low of 1.37 in Q2 2025.
  • Average Equity Ratio over 4 years is 0.22, with a median of 0.02 recorded in 2023.
  • Peak YoY movement for Equity Ratio: dropped 15.73% in 2023, then tumbled 208.16% in 2024.
  • A 4-year view of Equity Ratio shows it stood at 0.51 in 2022, then decreased by 15.73% to 0.43 in 2023, then crashed by 208.16% to 0.46 in 2024, then tumbled by 195.12% to 1.37 in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Equity Ratio are 1.37 (Q2 2025), 0.46 (Q2 2024), and 0.43 (Q2 2023).